【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Non-Rhabdomyosarcoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Non-Rhabdomyosarcoma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Non-Rhabdomyosarcoma to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Non-Rhabdomyosarcoma 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Non-Rhabdomyosarcoma Therapeutics Clinical Trials 31
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
Zeltia, S.A. 34
Clinical Trial Overview of Zeltia, S.A. 34
GlaxoSmithKline plc 35
Clinical Trial Overview of GlaxoSmithKline plc 35
Johnson & Johnson 36
Clinical Trial Overview of Johnson & Johnson 36
F. Hoffmann-La Roche Ltd. 37
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 37
Novartis AG 38
Clinical Trial Overview of Novartis AG 38
Merck & Co., Inc. 39
Clinical Trial Overview of Merck & Co., Inc. 39
Daiichi Sankyo Company, Limited 40
Clinical Trial Overview of Daiichi Sankyo Company, Limited 40
Clinical Trial Overview of Top Institutes / Government 41
National Cancer Institute 41
Clinical Trial Overview of National Cancer Institute 41
European Organization for Research and Treatment of Cancer 42
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 42
Children’s Oncology Group 43
Clinical Trial Overview of Children’s Oncology Group 43
Memorial Sloan Kettering Cancer Center 44
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 44
Fred Hutchinson Cancer Research Center 45
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 45
University of Heidelberg 46
Clinical Trial Overview of University of Heidelberg 46
Massachusetts General Hospital 47
Clinical Trial Overview of Massachusetts General Hospital 47
Institut Bergonie 48
Clinical Trial Overview of Institut Bergonie 48
Five Key Clinical Profiles 49
Appendix 77
Abbreviations 77
Definitions 77
Research Methodology 78
Secondary Research 78
About GlobalData 79
Contact Us 79
Disclaimer 79
Source 79
【レポート販売概要】
■ タイトル：非横紋筋肉腫(Non-Rhabdomyosarcoma)：世界の治験レビュー（2015年上半期版）■ 英文：Non-Rhabdomyosarcoma Global Clinical Trials Review, H1, 2015
■ 発行日：2015年2月18日
■ 調査会社：GlobalData
■ 商品コード：GDHC2566CTIDB
■ 調査対象地域：グローバル
- Emphysema：グローバル臨床試験レビューH2, 2013Emphysema Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Emphysema Global Clinical Trials Review, H2, 2013" provides data on the Emphysema clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Emphysema. It includes an overview of the trial numbers and their recruitment status as per the site of trial c …
- 世界の動物健康管理（医療）市場2014：主要企業の戦略的分析This report provides a worldwide strategic overview of the animal health market, including: Five-year forecasts for: - Major market segments - Key geographic regions Assessmen …
- 世界の家電市場予測2018The global consumer electronics industry has been growing significantly for the past few years due to the innovative technical developments in the sector across the globe. The industry is entering into the age of convergence wherein entirely different streams of digital-based audio, video and information technology unite and merge, removing entry hurdles across various markets and the whole indust …
- Home Automation: Solutions and Suppliers 2010Home Automation is the automatic control of a home's electronic systems, such as security, heating and air conditioning, entertainment, and lighting. A home automation system is one in which these systems are integrated into one, easy-to-use system. The purpose of a home automation system is to enable residents to perform normal daily tasks in a simpler manner. A home automation system will use sc …
- Sexually-Transmitted Diseases in the UK 2014: Market Outlook and Emerging OpportunitiesAbout This ReportThis new 280-page report from Venture Planning Group presents detailed analysis of the UK STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs. …
- 世界の主蒸気隔離弁市場2015The Global Main Steam Isolation Valves Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Main Steam Isolation Valves industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Main Steam Isolation Valves market analysis is provided for the international mark …
- 組織検査の世界市場：免疫組織化学、in situハイブリダイゼーション、デジタルパソロジー、ワークフロー管理、特殊染色法The global tissue diagnostics market is valued at USD 3,202.5 Million in 2015 and expected to reach USD 4,471.1 Million by 2020, at a CAGR of 6.9% from 2015 to 2020. A major driver for the growth of the tissue diagnostics industry is the increasing prevalence of cancer. On the other hand, the high degree of consolidation, stringent regulatory requirements, and lack of budgets are restraining the g …
- 眼科治療の世界市場2019-2023About this market The new drug approvals and strong drug pipeline will trigger the ophthalmology therapeutics market growth in the forthcoming years. Top players in the market are focusing on the development of disease-modifying drugs for treating the rising incidences of eye diseases. Furthermore, several market players are focusing on achieving new drug approvals and gene therapy approvals for t …
- 再生可能エネルギー産業2013Renewable Energy Industry in 2013: Expected Trends and Analysis Summary In recent years the global renewable industry has seen rapid growth backed by strong policy support. Globally, renewable energy total installed capacity grew from 374 Gigawatts (GW) in 2011 to 474 GW in 2012. It is expected that renewable energy installed capacity will reach 545 GW by the end of 2013. Wind is the most prominen …
- 政府向け生体認証システムの世界市場：地域別分析Summary This report offers detailed analysis of the global Government Biometric Systems market over the next ten years, and provides extensive market size forecasts by country and sub sector. It covers the key technological and market trends in the Government Biometric Systems market. Key Findings "The Global Government Biometric Systems Market 2015-2025 - Country Analysis: Market Profile" provide …
- ニューロモーフィック・チップの世界市場予測及び分析Neuromorphic chips are brain inspired electronic chips made out of multiple neurons. Combination of several artificial neural network chips is called Neuromorphic architecture. Current microprocessors can crunch numbers seamlessly, but they are terrible at tasks that brains do with ease. Motivation behind designing these chips is to build a platform for running large-scale, real-time simulations t …
- 先端巨大症/巨人症治療薬の世界市場機会分析OpportunityAnalyzer: Acromegaly and Gigantism - Opportunity Analysis and Forecast to 2018 Summary GlobalData estimates the 2013 sales for acromegaly and gigantism at approximately $588m across the 6MM covered in this report. The market will grow moderately at a CAGR of 3.74% during the five year forecast period, generating sales of approximately $707m at the end of 2018. Growing at a CAGR of 4.58% …
- 心臓バイオマーカーの世界市場：インサイト、市場機会、市場シェア、市場予測The global cardiac biomarker market is expected to generate the revenue of $2,225.9 million by 2022, registering a CAGR of 19.5% from 2016 to 2022. The prevention of cardiac diseases, by active monitoring the heart conditions by using cardiac biomarker testing is the newest approach for obtaining fastest output of immediate diagnosing and treatment of cardiac deceases. Cardiac biomarkers are made …
- アルミニウム線材の世界市場2015-2019Technavios market research analyst predicts the global aluminum wire rods market to grow at a CAGR of around 2% during the forecast period. The increased investments in infrastructure are driving the growth of this market. Developing economies such as India are heavily investing in infrastructure activities to improve industrialization. Initiatives like "Make in India" are anticipated to increase …
- 脳脊髄液管理の世界市場：製品別（シャント、外部ドレナージ装置）、最終用途別（小児、大人、高齢者）、地域別予測Global Cerebrospinal Fluid Management Market to reach USD 1.9 billion by 2025. Global Cerebrospinal Fluid Management Market valued approximately USD 1.18 billion in 2016 is anticipated to grow with a healthy growth rate of more than 5.2% over the forecast period 2017-2025. The driving force for the market conferences and workshops on basic science research and its translation into diagnosis and tr …
